Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis
The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in individuals with cystic fibrosis (CF) has increased significantly. While studies demonstrate that persistent MRSA infection in CF is associated with poor clinical outcomes, there are no randomized controlled studies informing management.
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Rebecca Dezube, Mark T. Jennings, Mary Rykiel, Marie Diener-West, Michael P. Boyle, James F. Chmiel, Elliott C. Dasenbrook Tags: Original Article Source Type: research
More News: Cystic Fibrosis | Infectious Diseases | MRSA | Respiratory Medicine | Staphylococcus Aureus | Study | Superbugs